These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9173939)

  • 21. Sex differences in the determinants of fibrinolytic activity.
    MacCallum PK; Cooper JA; Howarth DJ; Meade TW; Miller GJ
    Thromb Haemost; 1998 Mar; 79(3):587-90. PubMed ID: 9531046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
    Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
    Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exercise training enhances endogenous fibrinolysis in peripheral arterial disease.
    Killewich LA; Macko RF; Montgomery PS; Wiley LA; Gardner AW
    J Vasc Surg; 2004 Oct; 40(4):741-5. PubMed ID: 15472603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of exercise intensity, duration, and time of day on fibrinolytic activity in physically active men.
    Szymanski LM; Pate RR
    Med Sci Sports Exerc; 1994 Sep; 26(9):1102-8. PubMed ID: 7808243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in the fibrinolytic activity in hypertension and acute cerebral infarction].
    Guan KJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Jun; 21(3):150-2, 186-7. PubMed ID: 8243228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of red wine on the fibrinolytic system and the cellular activation reactions before and after exercise.
    Johansen KM; Skorpe S; Olsen JO; Osterud B
    Thromb Res; 1999 Dec; 96(5):355-63. PubMed ID: 10605950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal changes in tPA and PAI-1 after maximal exercise.
    Cooper JA; Nagelkirk PR; Coughlin AM; Pivarnik JM; Womack CJ
    Med Sci Sports Exerc; 2004 Nov; 36(11):1884-7. PubMed ID: 15514502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmyocardial fibrinolytic activity in patients with unstable angina pectoris.
    Daniel WC; Meidell RS; Hillis LD; Lange RA
    Coron Artery Dis; 1996 Jan; 7(1):45-9. PubMed ID: 8773432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction.
    Ganti AK; Potti A; Yegnanarayan R
    Pathophysiol Haemost Thromb; 2002; 32(2):80-4. PubMed ID: 12214153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of spironolactone on impaired fibrinolysis of hypertensive patients.
    Yalcin AI; Dincer M; Aslan V; Gulbas Z
    Kidney Blood Press Res; 2002; 25(4):260-4. PubMed ID: 12424430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinolytic activity and platelet release reaction in essential hypertension.
    Keskin A; Tombuloglu M; Büyükkeçeci F
    Jpn Heart J; 1994 Nov; 35(6):757-63. PubMed ID: 7897822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
    Fogari R; Zoppi A; Salvadeo SA; Mugellini A; Lazzari P; Santoro T; Derosa G
    Hypertens Res; 2011 Apr; 34(4):509-15. PubMed ID: 21179101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinolytic system in normotensive subjects and hypertensive patients.
    Armas-Hernández MJ; Hernández-Hernández R; Armas-Padilla MC; Sosa-Canache B; Cammarata R; Pacheco B; Guerrero-Pajuelo J; Israili ZH; Valasco M
    Am J Ther; 2007; 14(2):177-82. PubMed ID: 17414587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between heart rate recovery after exercise testing and plasminogen activator inhibitor 1, tissue plasminogen activator, and fibrinogen in apparently healthy men.
    Jae SY; Carnethon MR; Ahn ES; Heffernan KS; Choi YH; Lee MK; Fernhall B
    Atherosclerosis; 2008 Mar; 197(1):415-9. PubMed ID: 17681507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of aerobic and anaerobic physical conditioning on fibrinolysis.
    De Paz JA; Lasierra J; Villa JG; Vilades E; Gonzalez-Gallego J
    J Sports Med Phys Fitness; 1995 Dec; 35(4):263-7. PubMed ID: 8776073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.
    Mehta P; Parker RI
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters.
    Kaşifoğlu T; Yalçin AU
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):143-7. PubMed ID: 16766279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
    Stegnar M; Mavri A
    Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.